Plus: Novo Nordisk’s stock slumps after its said semaglutide didn’t slow Alzheimer’s disease in two late-stage clinical trials. And former Fox News host Tucker Carlson has launched a precious-metals company. Alex Ossola hosts.

Sign up for WSJ’s free What’s News newsletter.

An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.

Learn more about your ad choices. Visit megaphone.fm/adchoices